Bluewillow Biologics Inc.

Ann Arbor, MI Doing business as Bluewillow Biologics

UEI
RL3UZ5ZDKFT8
CAGE
3HT71
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2311 Green Rd a, Ann Arbor, MI 48105, USA
Website
bluewillow.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Bluewillow Biologics Inc.

Bluewillow Biologics Inc. is a clinical stage biopharmaceutical company that develops and commercializes topical antiseptic and anti-infective products and intranasal vaccines using its proprietary nanotechnology platform with oil in water nano droplets. The company provides research, development, and manufacturing services to federal agencies, primarily the Department of Health and Human Services.

Through prime federal contracts, Bluewillow Biologics has provided research and development services for intranasal peptide immunotherapy vaccines for peanut allergy, formulated with its Nanovax oil in water nanoemulsion adjuvant. This Small Business Innovation Research Phase I contract was funded by the National Institutes of Health National Institute of Allergy and Infectious Diseases, with a potential value of over $3 million.

Through federal grants, Bluewillow Biologics has conducted research and development of a mucosal nanoemulsion-adjuvanted RSV vaccine using recombinant pre-fusion F protein. This project grant providing over $7 million in funding was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases. As a subrecipient on federal grants for tuberculosis vaccine development awarded to the University of Chicago, Bluewillow Biologics provided formulation and analytical services to develop and evaluate nanoemulsion-based TB vaccine candidates for animal studies.

Quick answers

What is Bluewillow Biologics Inc.'s UEI?

Bluewillow Biologics Inc.'s Unique Entity ID (UEI) in SAM.gov is RL3UZ5ZDKFT8.

What is Bluewillow Biologics Inc.'s CAGE code?

Bluewillow Biologics Inc.'s CAGE code is 3HT71.

What is Bluewillow Biologics Inc.'s primary NAICS code?

Bluewillow Biologics Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).

Where is Bluewillow Biologics Inc. located?

Bluewillow Biologics Inc.'s physical address in SAM.gov is 2311 Green Rd a, Ann Arbor, MI 48105, USA.

Is Bluewillow Biologics Inc. registered in SAM.gov?

Yes. Bluewillow Biologics Inc.'s SAM.gov registration is active through March 23, 2027.

What is Bluewillow Biologics Inc.'s most recent federal award?

Bluewillow Biologics Inc.'s most recent federal grant award is Development of a mucosal nanoemulsion-adjuvanted RSV vaccine using recombinant pre-fusion f protein (R44AI145431), from National Institute of Allergy and Infectious Diseases, on September 1, 2020.

On GovTribe

See Bluewillow Biologics Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors